Abionyx Pharma SA (ABNX) — Free Cash Flow Generation Index
Latest as of December 2022:
0.73x
Abionyx Pharma SA (ABNX) has a Free Cash Flow Generation Index of 0.73x as of December 2022. Free cash flow of €157.00K represents 1% of operating cash flow (€214.00K). Explore Abionyx Pharma SA capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.73x
Free Cash Flow / Operating CF
Free Cash Flow
€157.00K
EUR
Operating Cash Flow
€214.00K
EUR
Capital Expenditures
€57.00K
EUR
Annual Free Cash Flow Generation for Abionyx Pharma SA (None–None)
Year-by-year Free Cash Flow Generation Index for Abionyx Pharma SA. Check how aggressively does Abionyx Pharma SA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).